Minerva Biotechnology and Biomolecular Research

eISSN: 2724-5934pISSN: 2724-542X

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SNIP
0.28

Journal Specifications

Overview
  • Publisher
    EDIZIONI MINERVA MEDICA
  • Frequency
    Quarterly
General Details
View less

Topics Covered

T-Cell Epitopes
Drug administration
3D printing
Coronavirus
Peptide vaccine

Recently Published Papers

FAQs

How frequently is the Minerva Biotechnology and Biomolecular Research published? Faqs

Minerva Biotechnology and Biomolecular Research is published Quarterly.

Who is the publisher of Minerva Biotechnology and Biomolecular Research? Faqs

The publisher of Minerva Biotechnology and Biomolecular Research is EDIZIONI MINERVA MEDICA.

How can I view the journal metrics of Minerva Biotechnology and Biomolecular Research on editage? Faqs

For the Minerva Biotechnology and Biomolecular Research metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Minerva Biotechnology and Biomolecular Research? Faqs

The eISSN number is 2724-5934 and pISSN number is 2724-542X for Minerva Biotechnology and Biomolecular Research.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding T-Cell Epitopes, Drug administration, 3D printing, Coronavirus, Peptide vaccine.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.